Literature DB >> 19532052

Immunopathogenesis of asymptomatic chronic HIV Infection: the calm before the storm.

Emily S Ford1, Camille E Puronen, Irini Sereti.   

Abstract

PURPOSE OF REVIEW: HIV and pathogenic simian immunodeficiency virus infection are characterized by chronic immune activation. This review addresses the factors that influence immune activation and may thus determine the rate of disease progression during the asymptomatic period of HIV. RECENT
FINDINGS: Immune activation stems from foreign antigen stimulation, including HIV, microbial products and coinfections and compensatory homeostatic mechanisms. Continuous immune stimulation creates a permissive environment for further viral replication, while temporarily allowing successful replenishment of the T-cell pool. Type I interferon, microbial translocation, activated (but ineffective) effector T cells, unruly regulatory T cells and inadequate T helper 17 cells all play important roles in the cycle of activation, functional exhaustion and T-cell death that leads to immunodeficiency.
SUMMARY: The asymptomatic chronic phase of HIV infection is a dynamic balance between host and virus, the outcome of which determines an individual's course of disease. Evaluation of the factors that determine the immunologic threshold of disease progression could assist in designing therapeutic strategies, including individualized timing of ART.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19532052      PMCID: PMC2760925          DOI: 10.1097/COH.0b013e328329c68c

Source DB:  PubMed          Journal:  Curr Opin HIV AIDS        ISSN: 1746-630X            Impact factor:   4.283


  108 in total

1.  TLR Ligand-Induced Type I IFNs Affect Thymopoiesis.

Authors:  Marie-Laurence Baron; Dominique Gauchat; Ross La Motte-Mohs; Nadia Kettaf; Ali Abdallah; Thomas Michiels; Juan-Carlos Zúñiga-Pflücker; Rafick-Pierre Sékaly
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

2.  Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors.

Authors:  Dimitrios I Zonios; Judith Falloon; John E Bennett; Pamela A Shaw; Doreen Chaitt; Michael W Baseler; Joseph W Adelsberger; Julia A Metcalf; Michael A Polis; Stephen B Kovacs; Stephen J Kovacs; Joseph A Kovacs; Richard T Davey; H Clifford Lane; Henry Masur; Irini Sereti
Journal:  Blood       Date:  2008-05-02       Impact factor: 22.113

Review 3.  Chronic innate immune activation as a cause of HIV-1 immunopathogenesis.

Authors:  Adriano Boasso; Gene M Shearer
Journal:  Clin Immunol       Date:  2007-10-03       Impact factor: 3.969

4.  Availability of activated CD4+ T cells dictates the level of viremia in naturally SIV-infected sooty mangabeys.

Authors:  Nichole R Klatt; Francois Villinger; Pavel Bostik; Shari N Gordon; Lara Pereira; Jessica C Engram; Ann Mayne; Richard M Dunham; Benton Lawson; Sarah J Ratcliffe; Donald L Sodora; James Else; Keith Reimann; Silvija I Staprans; Ashley T Haase; Jacob D Estes; Guido Silvestri; Aftab A Ansari
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

5.  Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut.

Authors:  Manuela Raffatellu; Renato L Santos; David E Verhoeven; Michael D George; R Paul Wilson; Sebastian E Winter; Ivan Godinez; Sumathi Sankaran; Tatiane A Paixao; Melita A Gordon; Jay K Kolls; Satya Dandekar; Andreas J Bäumler
Journal:  Nat Med       Date:  2008-03-23       Impact factor: 53.440

6.  CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals.

Authors:  Sunil K Ahuja; Hemant Kulkarni; Gabriel Catano; Brian K Agan; Jose F Camargo; Weijing He; Robert J O'Connell; Vincent C Marconi; Judith Delmar; Joseph Eron; Robert A Clark; Simon Frost; Jeffrey Martin; Seema S Ahuja; Steven G Deeks; Susan Little; Douglas Richman; Frederick M Hecht; Matthew J Dolan
Journal:  Nat Med       Date:  2008-03-30       Impact factor: 53.440

7.  Transcription factor FOXO3a controls the persistence of memory CD4(+) T cells during HIV infection.

Authors:  Julien van Grevenynghe; Francesco A Procopio; Zhong He; Nicolas Chomont; Catherine Riou; Yuwei Zhang; Sylvain Gimmig; Genevieve Boucher; Peter Wilkinson; Yu Shi; Bader Yassine-Diab; Elias A Said; Lydie Trautmann; Mohamed El Far; Robert S Balderas; Mohamed-Rachid Boulassel; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sekaly
Journal:  Nat Med       Date:  2008-03-02       Impact factor: 53.440

8.  HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells.

Authors:  James Arthos; Claudia Cicala; Elena Martinelli; Katilyn Macleod; Donald Van Ryk; Danlan Wei; Zhen Xiao; Timothy D Veenstra; Thomas P Conrad; Richard A Lempicki; Sherry McLaughlin; Massimiliano Pascuccio; Ravindra Gopaul; Jonathan McNally; Catherine C Cruz; Nina Censoplano; Eva Chung; Kristin N Reitano; Shyam Kottilil; Diana J Goode; Anthony S Fauci
Journal:  Nat Immunol       Date:  2008-02-10       Impact factor: 25.606

9.  Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro.

Authors:  John C Tilton; Maura M Manion; Marlise R Luskin; Alison J Johnson; Andy A Patamawenu; Claire W Hallahan; Nancy A Cogliano-Shutta; Joann M Mican; Richard T Davey; Shyam Kottilil; Jeffrey D Lifson; Julia A Metcalf; Richard A Lempicki; Mark Connors
Journal:  J Virol       Date:  2008-02-06       Impact factor: 5.103

Review 10.  Regulatory T cells in HIV infection: who's suppressing what?

Authors:  Nabila Seddiki; Anthony D Kelleher
Journal:  Curr HIV/AIDS Rep       Date:  2008-02       Impact factor: 5.495

View more
  30 in total

1.  Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection.

Authors:  Emily S Ford; Jamieson H Greenwald; Aaron G Richterman; Adam Rupert; Lauren Dutcher; Yunden Badralmaa; Ven Natarajan; Catherine Rehm; Colleen Hadigan; Irini Sereti
Journal:  AIDS       Date:  2010-06-19       Impact factor: 4.177

2.  An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses.

Authors:  Frank O Pettersen; Eirik A Torheim; Anders E A Dahm; Ingeborg S Aaberge; Andreas Lind; Malin Holm; Einar M Aandahl; Per M Sandset; Kjetil Taskén; Dag Kvale
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

3.  Plasma proteomic analysis of simian immunodeficiency virus infection of rhesus macaques.

Authors:  Jayme L Wiederin; Robert M Donahoe; James R Anderson; Fang Yu; Howard S Fox; Howard E Gendelman; Pawel S Ciborowski
Journal:  J Proteome Res       Date:  2010-09-03       Impact factor: 4.466

4.  Downregulation of robust acute type I interferon responses distinguishes nonpathogenic simian immunodeficiency virus (SIV) infection of natural hosts from pathogenic SIV infection of rhesus macaques.

Authors:  Levelle D Harris; Brian Tabb; Donald L Sodora; Mirko Paiardini; Nichole R Klatt; Daniel C Douek; Guido Silvestri; Michaela Müller-Trutwin; Ivona Vasile-Pandrea; Cristian Apetrei; Vanessa Hirsch; Jeffrey Lifson; Jason M Brenchley; Jacob D Estes
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

5.  Treatment of renal AA-Amyloidosis associated with human immunodeficiency virus infection: a case report.

Authors:  Janice Borg; Jesmar Buttigieg; Stephen Holwill; Charles Mallia Azzopardi
Journal:  CEN Case Rep       Date:  2020-09-05

6.  The hidden risk: Incorporating inflammation and HIV serostatus into coronary artery disease screening.

Authors:  Gregory A Payne; Edgar Turner Overton
Journal:  J Nucl Cardiol       Date:  2016-11-16       Impact factor: 5.952

7.  Patterns of HIV-1 protein interaction identify perturbed host-cellular subsystems.

Authors:  Jamie I MacPherson; Jonathan E Dickerson; John W Pinney; David L Robertson
Journal:  PLoS Comput Biol       Date:  2010-07-29       Impact factor: 4.475

8.  HIV-1 imposes rigidity on blood and semen cytokine networks.

Authors:  Andrea Lisco; Andrea Introini; Arshi Munawwar; Christophe Vanpouille; Jean-Charles Grivel; Paul Blank; Sarman Singh; Leonid Margolis
Journal:  Am J Reprod Immunol       Date:  2012-09-24       Impact factor: 3.886

9.  Reevaluating Cumulative HIV-1 Viral Load as a Prognostic Predictor: Predicting Opportunistic Infection Incidence and Mortality in a Ugandan Cohort.

Authors:  Joseph B Sempa; Jonathan Dushoff; Michael J Daniels; Barbara Castelnuovo; Agnes N Kiragga; Martin Nieuwoudt; Steven E Bellan
Journal:  Am J Epidemiol       Date:  2016-05-04       Impact factor: 4.897

10.  Elevated levels of innate immune modulators in lymph nodes and blood are associated with more-rapid disease progression in simian immunodeficiency virus-infected monkeys.

Authors:  Andre Durudas; Jeffrey M Milush; Hui-Ling Chen; Jessica C Engram; Guido Silvestri; Donald L Sodora
Journal:  J Virol       Date:  2009-09-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.